Advanced Search

Technical Analysis for IMNM - Immunome, Inc.

Grade Last Price % Change Price Change
B 14.68 3.53% 0.50
IMNM closed up 3.53 percent on Friday, January 22, 2021, on 56 percent of normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong N/A Up Up
Historical IMNM trend table...
Date Alert Name Type % Chg
180 Bullish Setup Bullish Swing Setup 0.00%
Wide Bands Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
Slingshot Bullish Bullish Swing Setup 3.53%
Wide Bands Range Expansion 3.53%
Overbought Stochastic Strength 3.53%
New 52 Week Closing High Bullish -3.55%
Narrow Range Bar Range Contraction -3.55%
NR7 Range Contraction -3.55%
Upper Bollinger Band Walk Strength -3.55%
Older End-of-Day Signals for IMNM ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Up 3% 1 day ago
Up 2% 1 day ago
Up 1% 1 day ago
60 Minute Opening Range Breakout 1 day ago
Down 2 % 1 day ago
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Get Started for Free!
Configure default chart indicators Basic chart:

Profile

  • Earnings date: ???
Immunome Inc., a biotechnology company, discovers, develops, and commercializes highly targeted and native human cancer antibodies against universal cancer antigens. Its RealMAb technology enables the discovery of novel antigens and the cognate native human antibodies that target antigens; and ScreenMab multiplex functional screening technology identifies monoclonal antibodies that have exquisite for tumor neoantigens. The company was founded in 2006 and is based in Exton, Pennsylvania.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Clinical Medicine Immunology Immune System Antibodies Monoclonal Antibodies Monoclonal Antibody Cancer Immunotherapy Multiplex Tumor Antibody Glycoproteins Antigen

Is IMNM a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

Recent News

Date Title
Jan 17 How Much Are Immunome, Inc. (NASDAQ:IMNM) Insiders Spending On Buying Shares?
Dec 30 The Daily Biotech Pulse: Osmotica Faces Second FDA Rejection, UK Conditionally Approves AstraZeneca's Vaccine Candidate, Hepion NASH Data
Dec 23 The Daily Biotech Pulse: Supernus Issues Positive ADHD Readout, Sorrento Files For Emergency Use Authorization For Rapid COVID-19 Test, Inhibikase To Make Wall Street Debut
Dec 10 Immunome Provides Organizational Update: Appoints Richard Baron to its Board of Directors and Sandra Stoneman as Chief Legal Officer and Corporate Secretary
Nov 25 The Daily Biotech Pulse: Revance's DAXI Regulatory Decision, Reata Slips On FDA Feedback, Liquidia Setback
Nov 17 Immunome EPS misses by $7.22
Nov 17 Immunome Reports Third Quarter 2020 Financial Results and Significant Progress
Oct 25 The Week Ahead In Biotech: Kala FDA Decision, Merck & Pfizer Earnings, Vaccine Updates And IPOs
Oct 11 Last Week's Notable Insider Buys: Element Solutions, Selecta Biosciences And More
Oct 6 The Daily Biotech Pulse: Pfizer, BioNTech Begin European Filing For Coronavirus Vaccine, Y-mAbs BLA Rejected, GlycoMimetics Granted Rare Pediatric Disease Designation
See more IMNM news...

Indicators

Indicator Value
52 Week High 16.77
52 Week Low 9.27
Average Volume 64,084
200-Day Moving Average 0.00
50-Day Moving Average 11.46
20-Day Moving Average 11.82
10-Day Moving Average 13.76
Average True Range 0.97
ADX 31.87
+DI 31.47
-DI 15.30
Chandelier Exit (Long, 3 ATRs ) 12.45
Chandelier Exit (Short, 3 ATRs ) 12.19
Upper Bollinger Band 15.98
Lower Bollinger Band 7.65
Percent B (%b) 0.84
BandWidth 70.48
MACD Line 1.00
MACD Signal Line 0.59
MACD Histogram 0.4148
Fundamentals Value
Market Cap 154.75 Million
Num Shares 10.5 Million
EPS
Price-to-Sales 0.00
Price-to-Book 12.88
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 16.22
Resistance 3 (R3) 16.11 15.49 15.97
Resistance 2 (R2) 15.49 15.09 15.54 15.88
Resistance 1 (R1) 15.08 14.85 15.28 15.19 15.79
Pivot Point 14.46 14.46 14.56 14.51 14.46
Support 1 (S1) 14.05 14.06 14.26 14.17 13.57
Support 2 (S2) 13.43 13.82 13.48 13.48
Support 3 (S3) 13.03 13.43 13.39
Support 4 (S4) 13.14